BOLD

SEC source: 0000950170-24-099296 · ownership.xml · derivative · entry 5

Rubin Jami · CIK 0001816484 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,420

Underlying: Common Stock · 51,420 shares

Expires 2034-02-14

F5 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 5, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on March 15, 2024.

SEC source: 0000950170-24-099296 · ownership.xml · derivative · entry 4

Rubin Jami · CIK 0001816484 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,666

Underlying: Common Stock · 196,666 shares

Expires 2033-07-25

F5 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 5, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: The stock option vested as to 25% of the underlying shares in connection with the consummation of the Issuer's initial public offering, and vests as to the remaining underlying shares in 36 substantially equal monthly installments beginning on August 31, 2024.

SEC source: 0000950170-24-099296 · ownership.xml · derivative · entry 3

Rubin Jami · CIK 0001816484 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 32,468 shares

Expires 2034-03-26

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 5, all other terms of the option remain unchanged.

F4 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly `installments beginning on April 27, 2024.

SEC source: 0000950170-24-099296 · ownership.xml · derivative · entry 2

Rubin Jami · CIK 0001816484 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 51,420 shares

Expires 2034-02-14

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 5, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on March 15, 2024.

SEC source: 0000950170-24-099296 · ownership.xml · derivative · entry 1

Rubin Jami · CIK 0001816484 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 196,666 shares

Expires 2033-07-25

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 5, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: The stock option vested as to 25% of the underlying shares in connection with the consummation of the Issuer's initial public offering, and vests as to the remaining underlying shares in 36 substantially equal monthly installments beginning on August 31, 2024.

SEC source: 0000950170-24-099306 · ownership.xml · derivative · entry 8

Hornby Zachary · CIK 0001602227 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,343

Underlying: Common Stock · 162,343 shares

Expires 2034-03-26

F6 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 6, all other terms of the option remain unchanged.

F5 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on April 27, 2024.

SEC source: 0000950170-24-099306 · ownership.xml · derivative · entry 7

Hornby Zachary · CIK 0001602227 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 257,207

Underlying: Common Stock · 257,207 shares

Expires 2034-02-14

F6 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 6, all other terms of the option remain unchanged.

F4 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on March 15, 2024.

SEC source: 0000950170-24-099306 · ownership.xml · derivative · entry 6

Hornby Zachary · CIK 0001602227 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 471,282

Underlying: Common Stock · 471,282 shares

Expires 2033-06-12

F6 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 6, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on July 13, 2023.

SEC source: 0000950170-24-099306 · ownership.xml · derivative · entry 5

Hornby Zachary · CIK 0001602227 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 256,410

Underlying: Common Stock · 256,410 shares

Expires 2031-06-06

F6 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 6, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on July 7, 2021.

SEC source: 0000950170-24-099306 · ownership.xml · derivative · entry 4

Hornby Zachary · CIK 0001602227 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 162,343 shares

Expires 2034-03-26

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 6, all other terms of the option remain unchanged.

F5 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on April 27, 2024.

SEC source: 0000950170-24-099306 · ownership.xml · derivative · entry 3

Hornby Zachary · CIK 0001602227 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 257,207 shares

Expires 2034-02-14

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 6, all other terms of the option remain unchanged.

F4 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on March 15, 2024.

SEC source: 0000950170-24-099306 · ownership.xml · derivative · entry 2

Hornby Zachary · CIK 0001602227 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 471,282 shares

Expires 2033-06-12

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 6, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on July 13, 2023.

SEC source: 0000950170-24-099306 · ownership.xml · derivative · entry 1

Hornby Zachary · CIK 0001602227 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 256,410 shares

Expires 2031-06-06

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 6, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on July 7, 2021.

SEC source: 0000950170-24-099303 · ownership.xml · derivative · entry 10

Abdollahian Neil · CIK 0001678223 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,191

Underlying: Common Stock · 23,191 shares

Expires 2034-03-26

F7 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F6 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on April 27, 2024.

SEC source: 0000950170-24-099303 · ownership.xml · derivative · entry 9

Abdollahian Neil · CIK 0001678223 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,852

Underlying: Common Stock · 36,852 shares

Expires 2034-02-14

F7 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F5 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on March 15, 2024.

SEC source: 0000950170-24-099303 · ownership.xml · derivative · entry 8

Abdollahian Neil · CIK 0001678223 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,871

Underlying: Common Stock · 54,871 shares

Expires 2033-06-12

F7 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F4 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on July 13, 2023.

SEC source: 0000950170-24-099303 · ownership.xml · derivative · entry 7

Abdollahian Neil · CIK 0001678223 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,948

Underlying: Common Stock · 19,948 shares

Expires 2031-12-05

F7 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on January 6, 2022.

SEC source: 0000950170-24-099303 · ownership.xml · derivative · entry 6

Abdollahian Neil · CIK 0001678223 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,051

Underlying: Common Stock · 82,051 shares

Expires 2031-09-14

F7 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: The stock option vested as to 25% of the underlying shares on August 9, 2022, and vests as to the remaining underlying shares in 36 substantially equal monthly installments thereafter.

SEC source: 0000950170-24-099303 · ownership.xml · derivative · entry 5

Abdollahian Neil · CIK 0001678223 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,191 shares

Expires 2034-03-26

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F6 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on April 27, 2024.

SEC source: 0000950170-24-099303 · ownership.xml · derivative · entry 4

Abdollahian Neil · CIK 0001678223 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 36,852 shares

Expires 2034-02-14

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F5 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on March 15, 2024.

SEC source: 0000950170-24-099303 · ownership.xml · derivative · entry 3

Abdollahian Neil · CIK 0001678223 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 54,871 shares

Expires 2033-06-12

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F4 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on July 13, 2023.

SEC source: 0000950170-24-099303 · ownership.xml · derivative · entry 2

Abdollahian Neil · CIK 0001678223 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,948 shares

Expires 2031-12-05

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on January 6, 2022.

SEC source: 0000950170-24-099303 · ownership.xml · derivative · entry 1

Abdollahian Neil · CIK 0001678223 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 82,051 shares

Expires 2031-09-14

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: The stock option vested as to 25% of the underlying shares on August 9, 2022, and vests as to the remaining underlying shares in 36 substantially equal monthly installments thereafter.

SEC source: 0000950170-24-099308 · ownership.xml · derivative · entry 10

Hassig Christian · CIK 0001730657 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,703

Underlying: Common Stock · 48,703 shares

Expires 2034-03-26

F7 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F6 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on April 27, 2024.

SEC source: 0000950170-24-099308 · ownership.xml · derivative · entry 9

Hassig Christian · CIK 0001730657 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,173

Underlying: Common Stock · 76,173 shares

Expires 2034-02-14

F7 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F5 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on March 15, 2024.

SEC source: 0000950170-24-099308 · ownership.xml · derivative · entry 8

Hassig Christian · CIK 0001730657 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,871

Underlying: Common Stock · 94,871 shares

Expires 2033-06-12

F7 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F4 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on July 13, 2023.

SEC source: 0000950170-24-099308 · ownership.xml · derivative · entry 7

Hassig Christian · CIK 0001730657 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,820

Underlying: Common Stock · 62,820 shares

Expires 2031-06-06

F7 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on July 7, 2021.

SEC source: 0000950170-24-099308 · ownership.xml · derivative · entry 6

Hassig Christian · CIK 0001730657 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,256

Underlying: Common Stock · 10,256 shares

Expires 2030-12-01

F7 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: The stock option vested as to 25% of the underlying shares on January 1, 2022, and vests as to the remaining underlying shares in 36 substantially equal monthly installments thereafter.

SEC source: 0000950170-24-099308 · ownership.xml · derivative · entry 5

Hassig Christian · CIK 0001730657 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 48,703 shares

Expires 2034-03-26

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F6 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on April 27, 2024.

SEC source: 0000950170-24-099308 · ownership.xml · derivative · entry 4

Hassig Christian · CIK 0001730657 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 76,173 shares

Expires 2034-02-14

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F5 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on March 15, 2024.

SEC source: 0000950170-24-099308 · ownership.xml · derivative · entry 3

Hassig Christian · CIK 0001730657 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 94,871 shares

Expires 2033-06-12

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F4 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on July 13, 2023.

SEC source: 0000950170-24-099308 · ownership.xml · derivative · entry 2

Hassig Christian · CIK 0001730657 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 62,820 shares

Expires 2031-06-06

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on July 7, 2021.

SEC source: 0000950170-24-099308 · ownership.xml · derivative · entry 1

Hassig Christian · CIK 0001730657 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,256 shares

Expires 2030-12-01

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 7, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: The stock option vested as to 25% of the underlying shares on January 1, 2022, and vests as to the remaining underlying shares in 36 substantially equal monthly installments thereafter.

SEC source: 0000950170-24-099307 · ownership.xml · derivative · entry 14

Oien Jessica · CIK 0001760712 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,234

Underlying: Common Stock · 16,234 shares

Expires 2034-03-26

F9 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 9, all other terms of the option remain unchanged.

F8 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on April 27, 2024.

SEC source: 0000950170-24-099307 · ownership.xml · derivative · entry 13

Oien Jessica · CIK 0001760712 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,090

Underlying: Common Stock · 26,090 shares

Expires 2034-02-14

F9 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 9, all other terms of the option remain unchanged.

F7 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on March 15, 2024.

SEC source: 0000950170-24-099307 · ownership.xml · derivative · entry 12

Oien Jessica · CIK 0001760712 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,897

Underlying: Common Stock · 35,897 shares

Expires 2033-12-12

F9 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 9, all other terms of the option remain unchanged.

F6 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on January 13, 2024.

SEC source: 0000950170-24-099307 · ownership.xml · derivative · entry 11

Oien Jessica · CIK 0001760712 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,051

Underlying: Common Stock · 42,051 shares

Expires 2033-06-12

F9 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 9, all other terms of the option remain unchanged.

F5 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on July 13, 2023.

SEC source: 0000950170-24-099307 · ownership.xml · derivative · entry 10

Oien Jessica · CIK 0001760712 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,200

Underlying: Common Stock · 10,200 shares

Expires 2032-12-12

F9 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 9, all other terms of the option remain unchanged.

F4 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on January 13, 2023.

SEC source: 0000950170-24-099307 · ownership.xml · derivative · entry 9

Oien Jessica · CIK 0001760712 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,148

Underlying: Common Stock · 29,148 shares

Expires 2031-12-05

F9 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 9, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on January 6, 2022.

SEC source: 0000950170-24-099307 · ownership.xml · derivative · entry 8

Oien Jessica · CIK 0001760712 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,051

Underlying: Common Stock · 32,051 shares

Expires 2031-09-14

F9 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 9, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: The stock option vested as to 25% of the underlying shares on August 30, 2022, and vests as to the remaining underlying shares in 36 substantially equal monthly installments thereafter.

SEC source: 0000950170-24-099307 · ownership.xml · derivative · entry 7

Oien Jessica · CIK 0001760712 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,234 shares

Expires 2034-03-26

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 9, all other terms of the option remain unchanged.

F8 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on April 27, 2024.

SEC source: 0000950170-24-099307 · ownership.xml · derivative · entry 6

Oien Jessica · CIK 0001760712 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 26,090 shares

Expires 2034-02-14

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 9, all other terms of the option remain unchanged.

F7 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on March 15, 2024.

SEC source: 0000950170-24-099307 · ownership.xml · derivative · entry 5

Oien Jessica · CIK 0001760712 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,897 shares

Expires 2033-12-12

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 9, all other terms of the option remain unchanged.

F6 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on January 13, 2024.

SEC source: 0000950170-24-099307 · ownership.xml · derivative · entry 4

Oien Jessica · CIK 0001760712 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 42,051 shares

Expires 2033-06-12

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 9, all other terms of the option remain unchanged.

F5 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on July 13, 2023.

SEC source: 0000950170-24-099307 · ownership.xml · derivative · entry 3

Oien Jessica · CIK 0001760712 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,200 shares

Expires 2032-12-12

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 9, all other terms of the option remain unchanged.

F4 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on January 13, 2023.

SEC source: 0000950170-24-099307 · ownership.xml · derivative · entry 2

Oien Jessica · CIK 0001760712 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 29,148 shares

Expires 2031-12-05

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 9, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on January 6, 2022.

SEC source: 0000950170-24-099307 · ownership.xml · derivative · entry 1

Oien Jessica · CIK 0001760712 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 32,051 shares

Expires 2031-09-14

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 9, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: The stock option vested as to 25% of the underlying shares on August 30, 2022, and vests as to the remaining underlying shares in 36 substantially equal monthly installments thereafter.

SEC source: 0000950170-24-099299 · ownership.xml · derivative · entry 10

Wagner Klaus W. · CIK 0001766477 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,745

Underlying: Common Stock · 41,745 shares

Expires 2034-03-26

F7 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 7, all other terms of the option remain unchanged.

F6 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on April 27, 2024.

SEC source: 0000950170-24-099299 · ownership.xml · derivative · entry 9

Wagner Klaus W. · CIK 0001766477 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,080

Underlying: Common Stock · 68,080 shares

Expires 2034-02-14

F7 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 7, all other terms of the option remain unchanged.

F5 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on March 15, 2024.

SEC source: 0000950170-24-099299 · ownership.xml · derivative · entry 8

Wagner Klaus W. · CIK 0001766477 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,871

Underlying: Common Stock · 94,871 shares

Expires 2033-06-12

F7 · derivative.exercise_price: The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.

F2 · price: On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 7, all other terms of the option remain unchanged.

F4 · derivative.exercise_date: The stock option vests in 48 substantially equal monthly installments beginning on July 13, 2023.